Bob provides the overall vision for the company, establishes the broad scientific strategy, and plays the lead role in securing grant and investor financing. Prior to starting BellBrook Labs in May of 2002, Bob served for ten years as Vice President of R&D at PanVera Corporation, and previously served as Director of Manufacturing at Promega Corporation, both in Madison, Wisconsin. At PanVera he was one of two individuals who provided the scientific leadership for turning a startup into a profitable biotech company employing more than 100 people, and including a merger with Aurora Biosciences. During this time he participated in the development of the HTS reagent market in its infancy, helping to overcome initial pharma resistance to purchasing screening reagents. Some of the innovations he introduced to the market have been widely adapted, including the concept of integrated HTS assay kits incorporating purified drug target proteins and detection reagents, and HTS assays based on fluorescence polarization detection.

John manages the day-to-day operations of BellBrook Labs, overseeing Sales and Marketing, Finance and Accounting, and IT. John has over 15 years of business management experience in biotechnology and information technology, with an emphasis on sales and marketing. He initially served as a production manager for Sigma Chemicals, later transitioning to sales and marketing within Sigma, and then at Promega Corporation, where he started and managed their DNA typing business. In the latter role, John built a successful sales and marketing infrastructure for a highly technical market with a small number of key customers, a situation very similar to the HTS market. His activities included direct sales, training other sales people, building a customer database, and managing all of the marketing functions. His efforts led to a successful business unit that captured 60% of a multi-million dollar market in two years. John also served as the information technology manager for North American Insurance and Madison Newspapers.

Traci joined BellBrook Labs in April of 2006 as Senior Accountant. Prior to joining BellBrook Labs, Traci spent seven years with Invitrogen Drug Discovery Solutions, most recently in the position of Financial Analyst. Traci obtained her bachelor’s degree in Accounting from Upper Iowa University.

Karen joined BellBrook Labs in October 2007 as Director of Marketing.  She is responsible for the strategic direction of marketing and scientific communications for the company.  Prior to joining BellBrook, Karen held director level positions at Fisher Biosciences and Pierce Biotechnology in the areas of market intelligence and strategic analysis.   While at Fisher, she supported strategic decision making and forecasted market trends while working closely with executive management to support corporate objectives.  Prior to Fisher, she worked with Promega Corporation in the areas of market research, product management and technical support.  Karen holds a Ph.D. in Molecular and Cellular Biology from Oregon State University and a B.S. degree in Microbiology from Washington State University.

Bob joined BellBrook in October 2007 and is responsible for leading the sales and business development effort. He has previously held various positions in sales and marketing over the past 4 years for companies such as Upstate/Chemicon (now Millipore) and Invitrogen. Most of his previous experience has been in the drug discovery area, primarily focusing on working with clients to address their current and future needs. Before entering the industry sector, Bob completed his doctoral work at UC Santa Cruz in Molecular, Developmental, and Cellular Biology focusing on morphogenesis and neuronal development. He then followed with a post-doctoral position at Sandia National Labs focusing on proteomics. Bob also holds a BS degree from UC Santa Barbara in Biology. In his spare time, he enjoys having a "Tommy Bahama" moment with family and friends as well as being an avid SF 49ers fan . Aloha!

Rick joined BellBrook Labs in February 2007 as the Product Manager of Biochemical Products. Prior to joining BellBrook Labs Rick worked at PanVera/Invitrogen for nearly ten years having responsibilities in Product Management and Operations Management for recombinant protein and biochemical assay products and services. Previously Rick held Research and Development roles at Sandoz/Novartis, Biogen, the University of Vermont, and Wyeth-Ayerst Laboratories. Rick obtained his Bachelor of Science degree in Biochemistry from SUNY Plattsburgh.

Brad's bio

Tracy's bio

Rachel joined BellBrook Labs in March of 2005 as Marketing Manager. Her responsibilities include developing marketing strategies and communicating the value of BellBrook Labs to the marketplace. Prior to joining BellBrook Labs, Rachel served for 5 years as Product Manager-Life Science Research Products and earlier, Manager-Technical Services at PanVera Corporation. During that time she was responsible for raising product awareness and growing market share of a significant portion of life science research products, including a line of fluorescence-based tools for the drug discovery and research products markets. She was also responsible for organizing technical communication with customers and growing the technical services department. Rachel served 5 years at University Hospital as a Medical Technologist in Hematology/Oncology. A percentage of this position included responsibilities as an educator for the University of Wisconsin-Madison.

Karen directs and manages the R&D biochemical assay group. She joined BellBrook Labs in 2003 after four years as a Senior Research Scientist with PanVera in Madison, Wisconsin (now a part of Invitrogen). Previously, she served as Project Leader at Abbott Laboratories Ross Products Division in Columbus, Ohio, where she directed a program to improve the activity of recombinant glycosyltransferases and developed a cost-effective method for synthesizing unique oligosaccharides. In the last few years, Karen has focused on developing, fluorescence-based high throughput biochemical assays for evaluating key enzymes in drug discovery, including kinases, phosphatases, proteases, and drug metabolizing enzymes. She also has extensive experience in recombinant protein expression and purification methods. Karen earned both a B.S and Ph.D degree in Bacteriology from the University of Wisconsin-Madison and conducted postdoctoral studies at Ohio State University.

Matt's bio

Tony is focused on developing biochemical assays to facilitate drug discovery. Prior to joining BellBrook Labs, Tony worked as the Group Leader of Biology and Biochemistry Research at Quintessence Biosciences focusing on developing ribonuclease variants as cancer therapeutics. Earlier, as a Research Scientist at Invitrogen Drug Discovery, he developed biochemical assays and produced and characterized enzymes involved in drug discovery. Before graduate school, Tony worked in the Protein Manufacturing Groups at Promega Corporation and Roche Molecular Systems where he developed manufacturing protocols, process improvement and scale-up purification strategies, and performed quality assurance assays for both recombinant and native protein products. In addition, at Roche he was involved with technology transfer of the PCR protein product line and on training of manufacturing personnel.

Thane joined BellBrook Labs in July of 2003 as Senior Research Chemist and is responsible for chemistry research and development. Prior to joining BellBrook Labs, Thane served as Research Chemist/Production Scientist at EraGen Biosciences and was intimately involved in the development and commercialization of their AEGIS™ synthetic non-natural base pairs. Prior to joining EraGen, Thane worked at Custom Synthesis Services as a Senior Chemist, focusing on custom APIs, non-commercially available drug standards and labeled standards for major pharma. In addition to his biotechnology experience, Thane maintains a “Secret Clearance” from work previously done as a Staff Chemist at Midwest Research Institute. He holds a MSc. in Synthetic Organic Chemistry from the University of Nebraska-Lincoln and has completed his written, research and oral requirements for the Ph.D. He holds a B.S. Chm. in Chemistry from Creighton University.

Tom's bio

Mark K's bio

Meera's bio

In November 2005, Steve joined BellBrook Labs, where he leads the cell biology program and the development of advanced cellular assays combining microfluidics, 3-dimensional matrices, and co-culture. In his previous position, he ushered in the cell biology program at Panvera (now part of Invitrogen). Technology transfer and cell-based assay development were his initial focus. He went on to lead the nuclear receptor program, and later, as research area manager, was responsible for the science behind the custom collaborative biology program at Invitrogen. Steve earned a PhD in Biochemistry from University of Illinois - Chicago, studying the regulation of the mammalian cell cycle. Postdoctoral studies at Stanford and Northwestern University focused on signal transduction and experimental therapeutics in prostate cancer.

Allyson's bio

Victoria's bio

Elizabeth's bio

Ivar joined BellBrook Labs in March 2007, where he leads microfluidic device design and manufacturing. He received a M.S. degree in Electrical and Computer Engineering from the University of Iceland in 2003 studying fabrication processes for nano-electronic biosensors. He went on to earn a PhD degree in Biomedical Engineering from the University of Wisconsin - Madison in 2006 where his work focused on microfluidic systems and applications for cellular models of breast cancer.

Casey is a member of the Biomedical Engineering group. He is responsible for development and optimization of manufacturing processes for the iuvo Microconduit Array Platform.  Prior to joining BellBrook Labs he worked 7 years at the University of Wisconsin – Madison where he developed automated microscopy and DNA patterning using microfluidics.  Casey has Bachelor of Science degrees in Mathematics and Molecular Biology from the University of Wisconsin – Madison.

Andy joined BellBrook Labs in June of 2006. Prior to joining BellBrook Labs, he spent 3 years with Invitrogen Drug Discovery Solutions where he oversaw the Substrates and Probes Technologies as a part of the HTS Biochemical Manufacturing Team. He also played a key roll in developing the ToxBLAzer™ Substrate. Andy obtained his B.S in Cellular Physiology from the University of Wisconsin-Whitewater.

Corinne's bio